Galangin Regulates Mucin 5AC Gene Expression via the Nuclear Factor-κB Inhibitor α/Nuclear Factor-κB p65 Pathway in Human Airway Epithelial Cells

被引:0
|
作者
Hossain, Rajib [1 ,2 ]
Lee, Hyun Jae [3 ,4 ]
Lee, Choong Jae [1 ,2 ]
机构
[1] Chungnam Natl Univ, Sch Med, Dept Pharmacol, Daejeon 35015, South Korea
[2] Chungnam Natl Univ, Brain Korea FOUR Project Med Sci 21, Daejeon 35015, South Korea
[3] Sahmyook Univ, Smith Liberal Arts Coll, Grad Sch, Seoul 01795, South Korea
[4] Sahmyook Univ, Grad Sch, Dept Addict Sci, Seoul 01795, South Korea
关键词
MUC5AC; Pulmonary mucin; Galangin; MUC5AC MUCIN; SIGNALING PATHWAY; PHORBOL ESTER; ACTIVATION; APIGENIN; ROOT;
D O I
10.4062/biomolther.2024.140
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we investigated the effects of the flavonoid galangin on the expression of the mucin 5AC (MUC5AC) gene in airway cells. Human pulmonary epithelial NCI-H292 cells were pretreated with galangin for 30 min and then stimulated with phorbol 12-myristate 13-acetate (PMA) for 24 h. We also examined the effects of galangin on the PMA-induced nuclear factor-kappa B (NF-kappa B) signaling pathway. Galangin inhibited the production of glycoproteins and the expression of MUC5AC mRNA induced by PMA via prevention of NF-kappa B inhibitor alpha degradation and NF-kappa B p65 nuclear translocation. These findings indicated that galangin suppressed mucin gene expression by modulating the NF-kappa B signaling pathway in human pulmonary epithelial cells.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 50 条
  • [1] Nuclear factor-κB p65 regulates glutaminase I expression in human hepatocellular carcinoma
    Dong, Meng
    Miao, Lin
    Zhang, Fengmei
    Li, Shengshui
    Han, Jingzhi
    Yu, Ruohui
    Qie, Shuo
    ONCOTARGETS AND THERAPY, 2018, 11 : 3721 - 3729
  • [2] Nuclear factor- K B p65 subunit determines the fate of aging epithelial cells
    Gao, Tian
    Kawabata, Yuko
    Kiyoshima, Tamotsu
    Jimi, Eijiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 722
  • [3] Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit
    Vermeulen, L
    De Wilde, G
    Notebaert, S
    Vanden Berghe, W
    Haegeman, G
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 963 - 970
  • [4] Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-κB/inhibitor of nuclear factor-κB pathway
    Lv, Peng
    Luo, He-Sheng
    Zhou, Xiao-Ping
    Xiao, Yan-Jv
    Paul, Shelley Chireyath
    Si, Xin-Min
    Zhou, Yan-Hong
    ARCHIVES OF MEDICAL RESEARCH, 2007, 38 (01) : 15 - 27
  • [5] Nuclear factor-κB augments β2-adrenergic receptor expression in human airway epithelial cells
    Aksoy, MO
    Bin, W
    Yang, Y
    You, DY
    Kelsen, SG
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (05) : L1271 - L1278
  • [6] Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-κB activation
    Hsu, TC
    Nair, R
    Tulsian, P
    Camalier, CE
    Hegamyer, GA
    Young, MR
    Colburn, NH
    CANCER RESEARCH, 2001, 61 (10) : 4160 - 4168
  • [7] Nuclear factor-κB regulates endothelin-1 gene expression
    Ka, YK
    Ohkita, M
    Kanematsu, M
    Takaoka, M
    Matsumura, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 174P - 174P
  • [8] Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue
    Sasaki, N
    Morisaki, T
    Hashizume, K
    Yao, T
    Tsuneyoshi, M
    Noshiro, H
    Nakamura, K
    Yamanaka, T
    Uchiyama, A
    Tanaka, M
    Katano, M
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4136 - 4142
  • [9] Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue
    Yu, Liang-Liang
    Yu, Hong-Gang
    Yu, Jie-Ping
    Luo, He-Sheng
    Xu, Xi-Ming
    Li, Jun-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (22) : 3255 - 3260
  • [10] The p65 subunit of nuclear factor-κB is a molecular target for radiation sensitization of human squamous carcinoma cells
    Kim, KM
    Zhang, Y
    Kim, BY
    Jeong, SJ
    Lee, SA
    Kim, GD
    Dritschilo, A
    Jung, M
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (06) : 693 - 698